Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients

Figure 1 The term during which nephrotoxicity occurred due to cisplatin combination chemotherapy.

Figure 2 The cumulative dose of cisplatin/body surface area at which nephrotoxicity occurred due to cisplatin combination chemotherapy.

Figure 3 Receiver operating characteristic curves of pre acute renal failure serum creatinines and acute renal failure glomerular filtration rate. ¹Pre-acute renal failure serum creatinine (Pre-ARF SCRs) were checked immediately before the administration of the chemotherapy drug that caused the SCR to increase to > 1.5 mg/dL; ²ARF SCRs were checked at the time at which the value of SCR was highest after increasing the SCR > 1.5 mg/dL; 3ARF glomerular filtration rate (GFRs) were checked at the time at which the value of SCR was highest after increasing the SCR > 1.5 mg/dL.